ghk-cu peptide dosing protocol subcutaneous Ghk Protocol Peptide Dosage Chart
Description
Your provider determines this based on response, tolerability, and goals
This gives you a network of resources as you reintegrate into your daily life
2008 Jan 9;28(2):40714
Peptide therapy with DAC is an exception, with a half-life of approximately 68 days, allowing for less frequent dosing
